Marco A. Passini

5.7k total citations · 1 hit paper
52 papers, 4.5k citations indexed

About

Marco A. Passini is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Marco A. Passini has authored 52 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 23 papers in Physiology and 13 papers in Cell Biology. Recurrent topics in Marco A. Passini's work include Lysosomal Storage Disorders Research (22 papers), Virus-based gene therapy research (12 papers) and Neurogenetic and Muscular Disorders Research (11 papers). Marco A. Passini is often cited by papers focused on Lysosomal Storage Disorders Research (22 papers), Virus-based gene therapy research (12 papers) and Neurogenetic and Muscular Disorders Research (11 papers). Marco A. Passini collaborates with scholars based in United States, France and Italy. Marco A. Passini's co-authors include John H. Wolfe, Seng H. Cheng, Lamya S. Shihabuddin, Jie Bu, Yimin Hua, C. Frank Bennett, Frank Rigo, Gene Hung, Adrian R. Krainer and James C. Dodge and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Marco A. Passini

51 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model

2010 501 citations Yimin Hua, Kentaro Sahashi et al. Genes & Development profile →

Peers

Countries citing papers authored by Marco A. Passini

Since Specialization

Citations

This map shows the geographic impact of Marco A. Passini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco A. Passini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco A. Passini more than expected).

Fields of papers citing papers by Marco A. Passini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco A. Passini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco A. Passini. The network helps show where Marco A. Passini may publish in the future.

Co-authorship network of co-authors of Marco A. Passini

This figure shows the co-authorship network connecting the top 25 collaborators of Marco A. Passini. A scholar is included among the top collaborators of Marco A. Passini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco A. Passini. Marco A. Passini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A cell-penetrating peptide enhances delivery and efficacy of phosphorodiamidate morpholino oligomers in mdx mice 2022 ·Molecular Therapy — Nucleic Acids ·Li Gan, (unknown), Jenna Wood, (unknown), (unknown), Nelsa L. Estrella, Bruce M. Wentworth, Gunnar J. Hanson, Marco A. Passini	33
2	Translational Fidelity of Intrathecal Delivery of Self-Complementary AAV9–Survival Motor Neuron 1 for Spinal Muscular Atrophy 2014 ·Human Gene Therapy ·Marco A. Passini, Jie Bu, Amy M. Richards, Christopher M. Treleaven, Jennifer A. Sullivan, Catherine R. O’Riordan, Abraham Scaria, Adrian P. Kells, Lluı́s Samaranch, Waldy San Sebastián, Thais Federici, Massimo S. Fiandaca, Nicholas M. Boulis, Krystof S. Bankiewicz, Lamya S. Shihabuddin, Seng H. Cheng	72
3	SMN regulates axonal local translation via miR-183/mTOR pathway 2014 ·Human Molecular Genetics ·Min Jeong Kye, (unknown), Mary H. Wertz, (unknown), Bikem Akten, (unknown), Miriam Peters, Markus Rießland, Pierre Neveu, Brunhilde Wirth, Kenneth S. Kosik, S. Pablo Sardi, Umrao R. Monani, Marco A. Passini, Mustafa Şahin	118
4	Gene Transfer to the CNS Is Efficacious in Immune-primed Mice Harboring Physiologically Relevant Titers of Anti-AAV Antibodies 2012 ·Molecular Therapy ·Christopher M. Treleaven, Thomas J. Tamsett, Jie Bu, Jonathan A. Fidler, (unknown), Gregory D Hurlbut, Lisa Woodworth, Seng H. Cheng, Marco A. Passini, Lamya S. Shihabuddin, James C. Dodge	27
5	Merits of Combination Cortical, Subcortical, and Cerebellar Injections for the Treatment of Niemann-Pick Disease Type A 2012 ·Molecular Therapy ·Jie Bu, Karen M. Ashe, John R. Bringas, John Marshall, James C. Dodge, Mario A. Cabrera-Salazar, John Forsayeth, Edward H. Schuchman, Krystof S. Bankiewicz, Seng H. Cheng, Lamya S. Shihabuddin, Marco A. Passini	24
6	Prospects for the gene therapy of spinal muscular atrophy 2011 ·Trends in Molecular Medicine ·Marco A. Passini, Seng H. Cheng	23
7	CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy 2010 ·Journal of Clinical Investigation ·Marco A. Passini, Jie Bu, Eric M. Roskelley, Amy M. Richards, S. Pablo Sardi, Catherine R. O’Riordan, K. Klinger, Lamya S. Shihabuddin, Seng H. Cheng	235
8	Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model breakdown → 2010 ·Genes & Development ·Yimin Hua, Kentaro Sahashi, Gene Hung, Frank Rigo, Marco A. Passini, C. Frank Bennett, Adrian R. Krainer	501
9	Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters 2009 ·Gene Therapy ·Tajammul Husain, Marco A. Passini, Michael K. Parente, Nicholas Fraser, John H. Wolfe	28
10	Temporal Neuropathologic and Behavioral Phenotype of 6^neo/6^neoPompe Disease Mice 2008 ·Journal of Neuropathology & Experimental Neurology ·Richard L. Sidman, Tatyana V. Taksir, Jonathan A. Fidler, Michael Zhao, James C. Dodge, Marco A. Passini, Nina Raben, Beth L. Thurberg, Seng H. Cheng, Lamya S. Shihabuddin	74
11	Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann–Pick A disease 2008 ·Experimental Neurology ·James C. Dodge, Jennifer Clarke, Christopher M. Treleaven, Tatyana V. Taksir, Denise Griffiths, Wendy Yang, Jonathan A. Fidler, Marco A. Passini, Kenneth P. Karey, Edward H. Schuchman, Seng H. Cheng, Lamya S. Shihabuddin	60
12	Timing of Therapeutic Intervention Determines Functional and Survival Outcomes in a Mouse Model of Late Infantile Batten Disease 2007 ·Molecular Therapy ·Mario A. Cabrera-Salazar, Eric M. Roskelley, Jie Bu, Bradley L. Hodges, Nelson S. Yew, James C. Dodge, Lamya S. Shihabuddin, István Sohár, David E. Sleat, Ronald K. Scheule, Beverly L. Davidson, Seng H. Cheng, Peter Lobel, Marco A. Passini	65
13	Effective gene therapy for an inherited CNS disease in a large animal model 2005 ·Annals of Neurology ·Charles H. Vite, Joseph C. McGowan, Sumit N. Niogi, Marco A. Passini, Kenneth J. Drobatz, Mark E. Haskins, John H. Wolfe	103
14	Identification of Novel Biomarkers for Niemann–Pick Disease Using Gene Expression Analysis of Acid Sphingomyelinase Knockout Mice 2005 ·Molecular Therapy ·Rajwinder Dhami, Marco A. Passini, Edward H. Schuchman	23
15	AAV-Mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy 2005 ·Molecular Therapy ·Mohammad A. Rafi, Han Zhi Rao, Marco A. Passini, Mark Curtis, Marie T. Vanier, Mariam Zaka, Paola Luzi, John H. Wolfe, David A. Wenger	86
16	Gene Delivery to the Mouse Brain with Adeno-Associated Virus 2004 ·Humana Press eBooks ·Marco A. Passini, Deborah Watson, John H. Wolfe	24
17	Intracerebral Transplantation of Adult Mouse Neural Progenitor Cells into the Niemann-Pick-A Mouse Leads to a Marked Decrease in Lysosomal Storage Pathology 2004 ·Journal of Neuroscience ·Lamya S. Shihabuddin, (unknown), Michael R. Huff, James C. Dodge, Jennifer Clarke, Shannon L. Macauley, Wendy Yang, Tatyana V. Taksir, Geoffrey Parsons, Marco A. Passini, Fred H. Gage, G. R. Stewart	68
18	Adeno-associated virus vector-mediated transduction in the cat brain 2003 ·Gene Therapy ·Charles H. Vite, Marco A. Passini, Mark E. Haskins, John H. Wolfe	89
19	Cloning of zebrafishvsx1: Expression of apaired-like homeobox gene during CNS development 1998 ·Developmental Genetics ·Marco A. Passini, (unknown), (unknown), William S. Asch, Gregory A. Wray, Pamela A. Raymond, Nisson Schechter	43
20	Cloning of Zebrafish Neurofilament cDNAs for Plasticin and Gefiltin: Increased mRNA Expression in Ganglion Cells After Optic Nerve Injury 1998 ·Journal of Neurochemistry ·William S. Asch, Devin Leake, (unknown), Marco A. Passini, Francesco Argenton, Nisson Schechter	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact